- Acquired by Stryker Corporation for $220M, Mar 2019
- Raised $7M Series B, Dec 2016
- Raised $8M Series B, May 2015
About
OrthoSpace develops and commercializes simple-to-implant biodegradable balloon systems for the orthopedic market. The company aims to create effective solutions for orthopedics that reduce pain and increase patients' range of motion while preserving bone and joint structures. The company's InSpace is an alternative treatment for cases when the rotator cuff is deemed irreparable. The InSpace device, which is based on an implantable, biodegradable balloon system, is implanted in a minimally invasive procedure on an outpatient basis to help alleviate pain and shorten the rehabilitation period. The balloon creates a space between the two bones where friction causes the most pain. Once the spacer is in place, there is no longer friction between the bones and pain is reduced. This reduction in pain enables the body to recuperate faster than it would undergoing comparable surgical treatments. In addition, implementation does not involve hospitalization. The OrthoSpace InSpace has the CE mark and received FDA clearance in July 2021.
Funding history · 3 rounds · $17.6M total
Q&A
- What is OrthoSpace's primary product?
- OrthoSpace develops and commercializes the InSpace system, a simple-to-implant biodegradable balloon system designed for the orthopedic market, specifically as an alternative treatment for irreparable rotator cuff syndrome.
- When was OrthoSpace founded and where is it headquartered?
- OrthoSpace was founded in March 2009 and is headquartered in Caesarea, Israel.
- What was the total amount of funding raised by OrthoSpace before its acquisition?
- OrthoSpace raised a total of $17.6 million USD across multiple funding rounds.
- Which companies invested in OrthoSpace's Series B funding round in December 2016?
- The Series B funding round in December 2016 included investments from Triventures and Smith & Nephew.
- When did OrthoSpace receive FDA clearance for its InSpace device?
- OrthoSpace received FDA clearance for its InSpace device in July 2021.
- When and by whom was OrthoSpace acquired?
- OrthoSpace was acquired by Stryker Corporation in March 2019 for $220 million USD.
- What is the employee count for OrthoSpace?
- OrthoSpace has an employee count in the 11-50 range.
- Who is the CEO of OrthoSpace?
- Itay Barnea serves as the CEO of OrthoSpace.
Team · 13
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | orthospace.co.il |
|---|---|
| linkedin.com/company/2142019 |
Identifiers & details
| Legal name | OrthoSpace, Ltd. |
|---|---|
| Founded | 2009-3 |
| Employees (exact) | 13 |
Acquisitions & public offerings
Acquired by Stryker Corporation 2019-03 $220.0M
Radar intelligence
Patents
| EPO | 1 |
|---|
Publications (Crossref)
| Works | 2 |
|---|
Web history (Wayback)
| Domain | orthospace.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|